159 related articles for article (PubMed ID: 10688850)
1. Germline CDKN2A mutation implicated in predisposition to multiple myeloma.
Dilworth D; Liu L; Stewart AK; Berenson JR; Lassam N; Hogg D
Blood; 2000 Mar; 95(5):1869-71. PubMed ID: 10688850
[TBL] [Abstract][Full Text] [Related]
2. Germline
Jouenne F; Chauvot de Beauchene I; Bollaert E; Avril MF; Caron O; Ingster O; Lecesne A; Benusiglio P; Terrier P; Caumette V; Pissaloux D; de la Fouchardière A; Cabaret O; N'Diaye B; Velghe A; Bougeard G; Mann GJ; Koscielny S; Barrett JH; Harland M; Newton-Bishop J; Gruis N; Van Doorn R; Gauthier-Villars M; Pierron G; Stoppa-Lyonnet D; Coupier I; Guimbaud R; Delnatte C; Scoazec JY; Eggermont AM; Feunteun J; Tchertanov L; Demoulin JB; Frebourg T; Bressac-de Paillerets B
J Med Genet; 2017 Sep; 54(9):607-612. PubMed ID: 28592523
[TBL] [Abstract][Full Text] [Related]
3. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.
Hashemi J; Platz A; Ueno T; Stierner U; Ringborg U; Hansson J
Cancer Res; 2000 Dec; 60(24):6864-7. PubMed ID: 11156381
[TBL] [Abstract][Full Text] [Related]
4. Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway.
Levin T; Mæhle L
Fam Cancer; 2017 Apr; 16(2):257-265. PubMed ID: 27804060
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome.
Lynch HT; Brand RE; Hogg D; Deters CA; Fusaro RM; Lynch JF; Liu L; Knezetic J; Lassam NJ; Goggins M; Kern S
Cancer; 2002 Jan; 94(1):84-96. PubMed ID: 11815963
[TBL] [Abstract][Full Text] [Related]
6. Well-differentiated Pancreatic Neuroendocrine Tumor in a Patient With Familial Atypical Multiple Mole Melanoma Syndrome (FAMMM).
Noë M; Hackeng WM; de Leng WWJ; Vergeer M; Vleggaar FP; Morsink FHM; Wood LD; Hruban RH; Offerhaus GJA; Brosens LAA
Am J Surg Pathol; 2019 Sep; 43(9):1297-1302. PubMed ID: 31261289
[TBL] [Abstract][Full Text] [Related]
7. Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants.
Figl A; Thirumaran RK; Ugurel S; Gast A; Hemminki K; Kumar R; Schadendorf D
Arch Dermatol; 2007 Apr; 143(4):495-9. PubMed ID: 17438182
[TBL] [Abstract][Full Text] [Related]
8. Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma.
Ghiorzo P; Gargiulo S; Pastorino L; Nasti S; Cusano R; Bruno W; Gliori S; Sertoli MR; Burroni A; Savarino V; Gensini F; Sestini R; Queirolo P; Goldstein AM; Scarrà GB
Hum Mol Genet; 2006 Sep; 15(18):2682-9. PubMed ID: 16893909
[TBL] [Abstract][Full Text] [Related]
9. Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.
Lal G; Liu L; Hogg D; Lassam NJ; Redston MS; Gallinger S
Genes Chromosomes Cancer; 2000 Apr; 27(4):358-61. PubMed ID: 10719365
[TBL] [Abstract][Full Text] [Related]
10. Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma.
Platz A; Hansson J; Månsson-Brahme E; Lagerlof B; Linder S; Lundqvist E; Sevigny P; Inganäs M; Ringborg U
J Natl Cancer Inst; 1997 May; 89(10):697-702. PubMed ID: 9168184
[TBL] [Abstract][Full Text] [Related]
11. CDKN2A as a uveal and cutaneous melanoma susceptibility gene.
Kannengiesser C; Avril MF; Spatz A; Laud K; Lenoir GM; Bressac-de-Paillerets B
Genes Chromosomes Cancer; 2003 Nov; 38(3):265-8. PubMed ID: 14506702
[TBL] [Abstract][Full Text] [Related]
12. CDKN2A germline mutations in individuals with cutaneous malignant melanoma.
Orlow I; Begg CB; Cotignola J; Roy P; Hummer AJ; Clas BA; Mujumdar U; Canchola R; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Anton-Culver H; Zanetti R; Gallagher RP; Dwyer T; Rebbeck TR; Kanetsky PA; Wilcox H; Busam K; From L; Berwick M;
J Invest Dermatol; 2007 May; 127(5):1234-43. PubMed ID: 17218939
[TBL] [Abstract][Full Text] [Related]
13. Novel germline CDKN2A mutation associated with head and neck squamous cell carcinomas and melanomas.
Cabanillas R; Astudillo A; Valle M; de la Rosa J; Álvarez R; Durán NS; Cadiñanos J
Head Neck; 2013 Mar; 35(3):E80-4. PubMed ID: 22083977
[TBL] [Abstract][Full Text] [Related]
14. Melanoma candidate genes CDKN2A/p16/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predisposition.
Abdel-Rahman MH; Pilarski R; Massengill JB; Christopher BN; Noss R; Davidorf FH
Melanoma Res; 2011 Jun; 21(3):175-9. PubMed ID: 21412176
[TBL] [Abstract][Full Text] [Related]
15. CDKN2A germline mutations in familial pancreatic cancer.
Bartsch DK; Sina-Frey M; Lang S; Wild A; Gerdes B; Barth P; Kress R; Grützmann R; Colombo-Benkmann M; Ziegler A; Hahn SA; Rothmund M; Rieder H
Ann Surg; 2002 Dec; 236(6):730-7. PubMed ID: 12454511
[TBL] [Abstract][Full Text] [Related]
16. Germline mutation of ARF in a melanoma kindred.
Hewitt C; Lee Wu C; Evans G; Howell A; Elles RG; Jordan R; Sloan P; Read AP; Thakker N
Hum Mol Genet; 2002 May; 11(11):1273-9. PubMed ID: 12019208
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma.
Tsao H; Zhang X; Kwitkiwski K; Finkelstein DM; Sober AJ; Haluska FG
Arch Dermatol; 2000 Sep; 136(9):1118-22. PubMed ID: 10987867
[TBL] [Abstract][Full Text] [Related]
18. Germline CDKN2A mutations in childhood melanoma: a case of melanoma-pancreatic cancer syndrome.
Gironi LC; Colombo E; Farinelli P; Giorgione R; Bozzola C; Ogliara P; Pasini B
Int J Dermatol; 2015 Dec; 54(12):e553-5. PubMed ID: 26381259
[No Abstract] [Full Text] [Related]
19. A novel type of deletion in the CDKN2A gene identified in a melanoma-prone family.
Knappskog S; Geisler J; Arnesen T; Lillehaug JR; Lønning PE
Genes Chromosomes Cancer; 2006 Dec; 45(12):1155-63. PubMed ID: 17001621
[TBL] [Abstract][Full Text] [Related]
20. Germline CDKN2A mutations in Brazilian patients of hereditary cutaneous melanoma.
de Ávila AL; Krepischi AC; Moredo LF; Aguiar TF; da Silva FC; de Sá BC; de Nóbrega AF; Achatz MI; Duprat JP; Landman G; Carraro DM
Fam Cancer; 2014 Dec; 13(4):645-9. PubMed ID: 25023876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]